Sea Mild Biotechnology , Ltd. Overview
Sea Mild Biotechnology , Ltd. (7516.TWO) has a ROE of 24.09%, above the sector sector average of 11.73%.
Get informed when a big investor buys or sells
+ Follow24.09%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Sea Mild Biotechnology , Ltd. posts a ROE of 24.09%. That is above the sector sector average of 11.73%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a ROE near 11.73% is typical. Sea Mild Biotechnology , Ltd.'s 24.09% is higher that level. That is roughly 105.3% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Sea Mild Biotechnology , Ltd.'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 24.09%; use YoY and peer views to separate noise from signal.
Context for 7516.TWO's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.73%), and (3) consistency with growth and profitability. This page covers the first two; Sea Mild Biotechnology , Ltd.'s other metric pages and overview cover the third.
